All Practice Exams

100+ Free Arab Board Neurosurgery Final Written Practice Questions

Prepare for the Arab Board Neurosurgery Final Written Examination exam with instant access — no signup required.

✓ No registration✓ No credit card✓ No hidden fees✓ Start practicing immediately
100+ Questions
100% Free

Loading practice questions...

Sample Arab Board Neurosurgery Final Written Practice Questions

Try these sample questions to test your Arab Board Neurosurgery Final Written exam readiness. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1According to the 2021 WHO Classification of Tumors of the Central Nervous System, which molecular or histopathological feature is required to diagnose an adult diffuse astrocytoma as a Glioblastoma, IDH-wildtype (CNS WHO Grade 4), even in the absence of microvascular proliferation or necrosis?
A.EGFR amplification, TERT promoter mutation, or combined +7/-10 chromosome copy number changes
B.Homozygous deletion of CDKN2A/CDKN2B
C.Co-deletion of chromosome arms 1p and 19q with IDH1 R132H mutation
D.BRAF V600E point mutation with H3 K27M alteration
Explanation: In the 2021 WHO CNS tumor classification, an IDH-wildtype diffuse astrocytoma in adults is classified as Glioblastoma, IDH-wildtype (WHO Grade 4) if it exhibits microvascular proliferation, necrosis, or any one of three molecular criteria: TERT promoter mutation, EGFR gene amplification, or combined whole chromosome 7 gain and chromosome 10 loss (+7/-10). This molecular grading recognizes that these tumors follow a clinical course identical to histologically necrotic glioblastomas.
2Which Simpson grade of meningioma resection corresponds to macroscopically complete tumor removal with excision of its dural attachment and any abnormal hyperostotic bone?
A.Simpson Grade I
B.Simpson Grade II
C.Simpson Grade III
D.Simpson Grade IV
Explanation: Simpson Grade I resection is defined as complete macroscopic tumor removal with excision of the dural attachment and resection of any abnormal hyperostotic bone. Simpson Grade II is complete removal with coagulation of the dural attachment. Simpson Grade III is complete resection without dural resection or coagulation, and Grade IV is subtotal resection.
3A 38-year-old male undergoes gross total resection of a left frontal lobe mass. Histopathology demonstrates a diffuse glioma with uniform round nuclei and perinuclear halos ('fried-egg' appearance). Molecular analysis reveals an IDH1 R132H mutation and complete 1p/19q co-deletion. What is the definitive diagnosis and therapeutic implication?
A.Oligodendroglioma, IDH-mutant and 1p/19q-codeleted (WHO Grade 2 or 3); confers marked chemo-radiosensitivity to PCV
B.Astrocytoma, IDH-mutant (WHO Grade 2); resistant to alkylating chemotherapy
C.Glioblastoma, IDH-mutant (WHO Grade 4); requires immediate high-dose re-irradiation
D.Central neurocytoma; requires observation alone with no adjuvant therapy
Explanation: The co-occurrence of an IDH mutation and complete 1p/19q codeletion defines oligodendroglioma under the WHO classification. 1p/19q codeletion is both diagnostic and strongly predictive of prolonged progression-free and overall survival, with exceptional sensitivity to procarbazine, CCNU (lomustine), and vincristine (PCV) chemotherapy and radiation therapy.
4An IDH-mutant diffuse astrocytoma without microvascular proliferation or necrosis demonstrates homozygous deletion of CDKN2A/CDKN2B on fluorescence in situ hybridization (FISH). According to WHO 2021 criteria, what is the assigned tumor grade?
A.CNS WHO Grade 2
B.CNS WHO Grade 3
C.CNS WHO Grade 4
D.CNS WHO Grade 1
Explanation: Homozygous deletion of CDKN2A/B is a powerful molecular marker of poor prognosis in IDH-mutant astrocytomas. Under the 2021 WHO classification, the presence of CDKN2A/B homozygous deletion in an IDH-mutant astrocytoma mandates an automatic upgrade to CNS WHO Grade 4, even in the complete absence of microvascular proliferation or necrosis.
5A 52-year-old female presents with progressive hearing loss and ataxia. Brain MRI demonstrates a 3.8 cm cerebellopontine angle mass filling the internal auditory canal and cerebellopontine cistern, displacing the brainstem and deforming the fourth ventricle. What is the Koos classification grade of this vestibular schwannoma?
A.Koos Grade I
B.Koos Grade II
C.Koos Grade III
D.Koos Grade IV
Explanation: The Koos grading system classifies vestibular schwannomas: Grade I is purely intracanalicular (<1 cm); Grade II extends into the CP cistern without touching the brainstem (<=2 cm); Grade III contacts the brainstem without brainstem compression or fourth ventricle displacement (<=3 cm); and Grade IV is a large tumor (>3 cm) causing significant brainstem and cranial nerve compression and fourth ventricle deformation.
6Which molecular alteration is characteristically associated with the papillary variant of craniopharyngioma, distinguishing it from the adamantinomatous variant?
A.BRAF V600E point mutation
B.CTNNB1 (beta-catenin) exon 3 activating mutation
C.H3 K27M histone gene mutation
D.IDH1 R132H point mutation
Explanation: Papillary craniopharyngiomas, which occur almost exclusively in adults and lack calcifications, are driven by BRAF V600E mutations in over 95% of cases, making them responsive to targeted BRAF/MEK inhibitors (e.g., dabrafenib plus trametinib). In contrast, adamantinomatous craniopharyngiomas occur predominantly in children, contain wet keratin and calcifications, and are driven by activating mutations in CTNNB1 (beta-catenin).
7A 29-year-old female presents with galactorrhea, secondary amenorrhea, and a serum prolactin level of 280 ng/mL. Pituitary MRI reveals a 1.6 cm sellar mass with suprasellar extension touching the optic chiasm without visual field loss. What is the standard FIRST-LINE management?
A.Medical therapy with a dopamine agonist such as cabergoline
B.Urgent transsphenoidal microscopic tumor resection
C.Stereotactic radiosurgery with Gamma Knife
D.Fractionated external beam intensity-modulated radiation therapy
Explanation: Dopamine agonists (cabergoline or bromocriptine) are the first-line therapy for prolactinomas (both micro- and macro-adenomas). Cabergoline normalizes prolactin levels in >85% of patients and achieves significant tumor shrinkage in >80%, even when suprasellar extension is present, reserving transsphenoidal surgery for medical refractoriness, intolerance, or acute apoplexy with visual compromise.
8A 45-year-old male with a known non-functioning pituitary macroadenoma presents to the emergency department with sudden severe 'thunderclap' headache, bilateral visual acuity decline to 20/200, bitemporal hemianopia, and left third nerve palsy. MRI reveals acute intratumoral hemorrhage with chiasmal compression. What is the most appropriate immediate surgical management?
A.High-dose intravenous corticosteroids and urgent transsphenoidal surgical decompression
B.High-dose intravenous dexamethasone alone with serial visual field checks in 2 weeks
C.Urgent pterional craniotomy and subfrontal tumor resection
D.Immediate stereotactic radiosurgery to thrombose the hemorrhagic vessel
Explanation: Pituitary apoplexy with acute visual acuity deterioration, severe visual field deficit, or ophthalmoplegia is a neurosurgical emergency. Management requires immediate hemodynamic stabilization with IV stress-dose corticosteroids (to treat acute secondary adrenal insufficiency) followed by urgent transsphenoidal decompression to relieve optic chiasm and cavernous sinus compression.
9A 64-year-old immunocompetent male presents with subacute cognitive decline. Brain MRI demonstrates multiple periventricular, avidly and homogeneously enhancing masses with restricted diffusion on DWI, highly suspicious for primary CNS lymphoma (PCNSL). What is the critical diagnostic rule prior to performing stereotactic biopsy?
A.Withhold or discontinue systemic corticosteroids prior to biopsy to prevent tumor lysis and non-diagnostic tissue
B.Perform radical gross total resection via open craniotomy before initiating chemotherapy
C.Administer high-dose methotrexate 24 hours before biopsy to sensitize tumor cells
D.Administer whole-brain radiotherapy prior to obtaining histological confirmation
Explanation: Corticosteroids exert a profound cytotoxic and lympholytic effect on primary CNS lymphoma B-cells ('ghost tumors'), which can lead to rapid tumor regression and non-diagnostic histopathology. Corticosteroids must be withheld or rapidly tapered prior to stereotactic biopsy unless life-threatening cerebral herniation is imminent. PCNSL is treated with high-dose methotrexate-based chemotherapy; surgical resection provides no survival benefit and increases neurological morbidity.
10A 19-year-old male presents with Parinaud syndrome (upward gaze palsy, convergence-retraction nystagmus, light-near dissociation) and obstructive hydrocephalus. Brain MRI shows a heterogeneously enhancing pineal region mass. Serum and CSF tumor markers reveal markedly elevated alpha-fetoprotein (AFP) and mildly elevated beta-hCG. What is the most likely diagnosis?
A.Non-germinomatous germ cell tumor (e.g., embryonal carcinoma or yolk sac tumor component)
B.Pure pineal germinoma
C.Pineocytoma (WHO Grade 1)
D.Pineoblastoma (WHO Grade 4)
Explanation: Markedly elevated AFP in serum or CSF is pathognomonic for a non-germinomatous germ cell tumor (specifically yolk sac tumor or embryonal carcinoma). Pure germinomas typically have normal AFP and may have normal or mildly elevated beta-hCG. Pineal parenchymal tumors (pineocytoma, pineoblastoma) do not produce oncofetal markers (AFP or beta-hCG).

About the Arab Board Neurosurgery Final Written Exam

The Arab Board Neurosurgery Final Written Examination is the culminating cognitive exit evaluation required for specialist board certification by the Arab Board of Health Specializations (ABHS). Senior neurosurgery residents and specialist candidates are evaluated on complex diagnostic pathways, surgical indications, microdissection strategies, neuro-oncology guidelines, cerebrovascular revascularization, spinal reconstruction, pediatric neurosurgery, and neurocritical care management.

Assessment

A comprehensive final exit written examination of single-best-answer multiple-choice questions testing advanced clinical decision-making, operative technique, neuro-oncology, cerebrovascular disease, spine, trauma, and neurointensive care.

Time Limit

Approximately 3 hours

Passing Score

Approximately 60%, established by the Scientific Council of Neurosurgery using criterion-referenced standard-setting methods.

Exam Fee

Set by ABHS and national councils (Arab Board of Health Specializations (ABHS) - Scientific Council of Neurosurgery)

Arab Board Neurosurgery Final Written Exam Content Outline

18%

Neuro-Oncology & Skull Base Surgery

Pathophysiology, WHO 2021 molecular classification of CNS tumors (IDH1/2 mutation, 1p/19q codeletion, CDKN2A/B deletion, EGFR amplification), high-grade and low-grade gliomas, meningioma Simpson grading, vestibular schwannomas (Koos classification), sellar/suprasellar pathology (pituitary adenomas, craniopharyngiomas), intraoperative neurophysiological monitoring, and skull base approaches.

18%

Cerebrovascular Neurosurgery

Evaluation and management of subarachnoid hemorrhage (Hunt-Hess and Fisher grades), microsurgical clipping vs endovascular coiling (ISAT/BRAT guidelines), vasospasm and delayed cerebral ischemia management, arteriovenous malformations (Spetzler-Martin classification), cavernous malformations, dural AV fistulas (Borden/Cognard), spontaneous intracerebral hemorrhage (STICH trials), decompressive hemicraniectomy in malignant MCA infarction, and carotid endarterectomy vs stenting.

18%

Neurotrauma & Neurocritical Care

Brain Trauma Foundation (BTF 4th edition) guidelines, advanced intracranial pressure (ICP) and cerebral perfusion pressure (CPP) management, tiered therapy for refractory intracranial hypertension, decompressive craniectomy (DECRA, RESCUEicp), acute epidural and subdural hematomas, diffuse axonal injury, brain tissue oxygenation (PbtO2) and jugular venous saturation monitoring, and post-traumatic neuro-endocrine/electrolyte disturbances (SIADH, CSW, DI).

18%

Spine & Peripheral Nerve Surgery

Surgical management of cervical spondylotic myelopathy (anterior cervical discectomy/corpectomy vs posterior laminectomy/laminoplasty), lumbar disc herniation and lumbar spinal stenosis, spinal trauma classification systems (AOSpine, TLICS, SLIC), odontoid fracture management, spinal cord injury resuscitation (MAP goals 85-90 mmHg), intradural extramedullary vs intramedullary tumors, spinal sagittal balance parameters, and peripheral nerve entrapment/tumors.

14%

Pediatric Neurosurgery

Pathophysiology and treatment of pediatric hydrocephalus (VP shunting vs endoscopic third ventriculostomy with choroid plexus cauterization, ETV Success Score), nonsyndromic and syndromic craniosynostosis, open and closed spinal dysraphism (myelomeningocele, tethered cord syndrome), Chiari I and II malformations, pediatric posterior fossa neoplasms (medulloblastoma molecular subgroups, pilocytic astrocytoma, ependymoma), and vein of Galen malformations.

14%

Functional, Stereotactic & Epilepsy Surgery

Indications, anatomical targets, and clinical trial evidence for deep brain stimulation (DBS) in Parkinson's disease (STN vs GPi), essential tremor (VIM), and dystonia; stereotactic radiosurgery (SRS) indications and dosimetric principles for brain metastases, AVMs, and acoustic neuromas; evaluation and surgical procedures for medically refractory epilepsy (anterior temporal lobectomy, stereotactic laser ablation, responsive neurostimulation); microvascular decompression for trigeminal neuralgia; and normal pressure hydrocephalus workup.

How to Pass the Arab Board Neurosurgery Final Written Exam

What You Need to Know

  • Passing score: Approximately 60%, established by the Scientific Council of Neurosurgery using criterion-referenced standard-setting methods.
  • Assessment: A comprehensive final exit written examination of single-best-answer multiple-choice questions testing advanced clinical decision-making, operative technique, neuro-oncology, cerebrovascular disease, spine, trauma, and neurointensive care.
  • Time limit: Approximately 3 hours
  • Exam fee: Set by ABHS and national councils

Keys to Passing

  • Work through all 100 available questions
  • Review every answer and explanation
  • Track weak areas and revisit them
  • Use our AI tutor for tough concepts

Arab Board Neurosurgery Final Written Study Tips from Top Performers

1Review landmark clinical trials and consensus guidelines: Master key trials including ISAT, BRAT, STICH I/II, DECRA, RESCUEicp, DESTINY, NASCET, and the Brain Trauma Foundation 4th edition guidelines.
2Understand the 2021 WHO Classification of CNS Tumors: Familiarize yourself with integrated molecular diagnostics, including IDH1/2 mutations, 1p/19q codeletions, MGMT promoter methylation, CDKN2A/B homozygous deletion in astrocytomas, and H3 K27M alterations.
3Know spine trauma classification systems and surgical indications: Apply the AOSpine subaxial and thoracolumbar classification systems, TLICS score, and Anderson-D'Alonzo classification for odontoid fractures.
4Master neurointensive care protocols: Memorize target parameters for severe TBI (ICP < 22 mmHg, CPP 60-70 mmHg), acute spinal cord injury (MAP 85-90 mmHg for 7 days), and electrolyte differentiation between SIADH, CSW, and DI.

Frequently Asked Questions

What is the structure of the Arab Board Neurosurgery Final Written Examination?

The examination comprises single-best-answer multiple-choice questions (typically 150 MCQs across two written papers) administered over approximately 3 hours. It tests advanced clinical judgment, diagnostic reasoning, surgical indications, operative anatomy, complications management, and evidence-based neurosurgical critical care.

What is the standard passing mark for the ABHS Neurosurgery Final Written Exam?

The passing threshold is generally set at approximately 60% by the Scientific Council of Neurosurgery using psychometric criterion-referenced standard-setting methods. Candidates should check with their local accredited Arab Board office for current session-specific regulations.

Who is eligible to take the Arab Board Neurosurgery Final Written Exam?

Candidates must have successfully completed all required years of an accredited ABHS neurosurgery residency program, passed the Part 1 Basic Sciences Examination, logged required operative procedures, and received official authorization from their training program director and national specialty board committee.

How does the Final Written Exam differ from the Part 1 Examination?

While the Part 1 examination focuses primarily on foundational basic sciences (neuroanatomy, neurophysiology, neuropathology, and neuropharmacology), the Final Written Exam evaluates senior clinical competence, complex operative decision-making, major clinical trial evidence, complication rescue, and comprehensive patient management across all neurosurgical subspecialties.